| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Revenue | $1.2B | $1.2B | $1.2B | $1.1B | $0.7B | $0.5B |
| Cost of Revenue | — | — | — | — | — | — |
| Gross Profit | $1.0B | $1.0B | $1.1B | $0.9B | $0.6B | $0.4B |
| R&D Expense | $0.2B | $0.2B | $0.2B | $0.2B | $0.1B | $0.1B |
| SG&A Expense | — | — | — | — | — | — |
| Operating Income | $0.2B | $0.1B | $0.3B | $0.2B | $0.1B | $0.0B |
| Net Income | $0.1B | $0.0B | $0.1B | $0.1B | $0.1B | $-0.0B |
| EPS (Basic) | $0.38 | $0.08 | $0.27 | $0.16 | $0.46 | $-0.10 |
| EPS (Diluted) | $0.38 | $0.08 | $0.27 | $0.16 | $0.43 | $-0.11 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Total Assets | $6.4B | $6.5B | $6.9B | $7.1B | $6.9B | $2.3B |
| Current Assets | $0.5B | $0.5B | $0.9B | $0.8B | $0.5B | $0.5B |
| Cash & Equivalents | $0.2B | $0.1B | $0.4B | $0.4B | $0.3B | $0.3B |
| Total Liabilities | $4.9B | $4.8B | $4.7B | $4.9B | $4.9B | $1.4B |
| Current Liabilities | $0.6B | $0.7B | $0.6B | $0.6B | $0.5B | $0.3B |
| Stockholders' Equity | $1.5B | $1.7B | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.5B | $0.4B | $0.4B | $0.4B | $0.3B | $0.2B |
| Investing Cash Flow | $-0.1B | $0.0B | $0.0B | $-0.3B | $-0.7B | $-0.1B |
| Capital Expenditures | — | — | — | — | — | — |
| Financing Cash Flow | $-0.3B | $-0.7B | $-0.4B | $-0.0B | $0.4B | $0.2B |